Stockscreener 앱 받기
131.63
0.74%
0.97
전일 마감가:
$130.66
열려 있는:
$131.72
하루 거래량:
870.15K
Relative Volume:
0.61
시가총액:
$10.63B
수익:
$8.19B
순이익/손실:
$758.19M
주가수익비율:
14.34
EPS:
9.18
순현금흐름:
$1.06B
1주 성능:
-1.74%
1개월 성능:
-8.30%
6개월 성능:
-30.59%
1년 성능:
-58.32%
1일 변동 폭
$129.25
$133.62
1주일 범위
$129.25
$142.58
52주 변동 폭
$129.25
$347.72
Icon Plc Stock (ICLR) Company Profile
ICLR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
131.63 | 10.65B | 8.19B | 758.19M | 1.06B | 9.18 |
|
TMO
Thermo Fisher Scientific Inc
|
412.06 | 152.18B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
196.11 | 135.78B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
518.10 | 39.54B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
113.77 | 30.49B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
142.82 | 25.78B | 15.50B | 1.33B | 2.16B | 7.34 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-29 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-04-14 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-04-10 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-03-21 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-01-07 | 개시 | RBC Capital Mkts | Outperform |
| 2024-10-24 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | 개시 | Redburn Atlantic | Neutral |
| 2024-09-18 | 개시 | Leerink Partners | Outperform |
| 2024-06-06 | 개시 | Goldman | Buy |
| 2023-12-15 | 개시 | Truist | Buy |
| 2023-09-13 | 개시 | TD Cowen | Outperform |
| 2023-01-17 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-01-13 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-11-09 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-09-07 | 개시 | UBS | Buy |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-05-24 | 개시 | Guggenheim | Buy |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2021-09-27 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-23 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-07-14 | 개시 | Citigroup | Neutral |
| 2021-04-13 | 재개 | BofA Securities | Neutral |
| 2021-04-01 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | 개시 | Barclays | Equal Weight |
| 2021-03-01 | 업그레이드 | UBS | Neutral → Buy |
| 2021-02-26 | 업그레이드 | Truist | Hold → Buy |
| 2020-07-24 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-04-20 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-03-02 | 개시 | Deutsche Bank | Hold |
| 2020-01-27 | 다운그레이드 | SunTrust | Buy → Hold |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-09-23 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | 업그레이드 | UBS | Sell → Neutral |
| 2019-01-25 | 업그레이드 | Mizuho | Neutral → Buy |
| 2018-10-26 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-10-09 | 개시 | UBS | Sell |
| 2018-04-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2018-02-15 | 재확인 | Mizuho | Neutral |
| 2018-01-19 | 개시 | Evercore ISI | Outperform |
| 2017-10-27 | 재확인 | Barclays | Equal Weight |
| 2017-09-11 | 개시 | BofA/Merrill | Buy |
| 2017-07-31 | 업그레이드 | SunTrust | Hold → Buy |
| 2017-07-27 | 재확인 | Mizuho | Neutral |
| 2017-06-29 | 업그레이드 | Jefferies | Hold → Buy |
모두보기
Icon Plc 주식(ICLR)의 최신 뉴스
Icon (ICLR) Price Target Reduced by Mizuho to $173 | ICLR Stock News - GuruFocus
ICON Life Science Internship For BSc & MSc – Applications Closing Soon! Hurry! - BioTecNika
Daily Progress: Icon Plc (ICLR) Drop -5.54, Closing at 135.10 - DWinneX
Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies | ICLR Stock News - GuruFocus
Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies - Business Wire
Icon (ICLR) Stock Target Reduced Amid Market Challenges | ICLR S - GuruFocus
Icon (ICLR) Stock Target Reduced Amid Market Challenges | ICLR Stock News - GuruFocus
ICON plc (ICLR) Consensus: A 29% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews
Icon Plc Earnings Call: Navigating Challenges and Opportunities - TipRanks
Icon (ICLR) Sees Price Target Adjustment by Barclays | ICLR Stock News - GuruFocus
ICON plc Expands Share Buyback Program Amid Vaccine Study Delays and Tariff Uncertainty - TipRanks
Icon Plc [ICLR] Officer makes an insider purchase of 1,540 shares worth 0.29 million. - knoxdaily.com
Market Analysts see Icon Plc [ICLR] gaining to $150. Time to buy? - dbtnews.com
Icon (ICLR) Price Target Reduced by BofA Analyst | ICLR Stock Ne - GuruFocus
ICLR Faces Revenue Pressure Amid Elevated Cancellations - GuruFocus
Barclays Adjusts Price Target for Icon (ICLR) Amid Uncertain Out - GuruFocus
Barclays Adjusts Price Target for Icon (ICLR) Amid Uncertain Outlook | ICLR Stock News - GuruFocus
Icon PLC (ICLR) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Initiatives - Yahoo Finance
ICON plc Reports Q1 2025 Financial Results - TipRanks
Icon Earnings: Macroeconomic Issues and Trial Delays Affect Our Near-Term View - Morningstar
Narrow-Moat Icon Faces Macroeconomic Issues and Trial Delays That Constrain Its Near-Term Outlook - Morningstar
The Future of Icon Plc: Analyzing ICLR - investchronicle.com
A look at ICLR’s current quarter earnings estimates - uspostnews.com
ICON's Q1 Earnings Surpass Estimates, Revenues Lag, Stock Down - Yahoo Finance
Icon PLC: Q1 Earnings Snapshot - MySA
ICON PLC earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Icon PLC (ICLR) Beats Q1 Earnings Estimates - Yahoo Finance
ICON PLC reports results for the quarter ended March 31Earnings Summary - TradingView
ICON PLC earnings beat, revenue fell short of estimates - Investing.com
ICON plc Reports Q1 2025 Financial Results Amid Market Challenges - TipRanks
ICON Reports First Quarter 2025 Results | ICLR Stock News - GuruFocus
Earnings Flash (ICLR) ICON PLC Reports Q1 Adjusted EPS $3.19, vs. FactSet Est of $3.10 - marketscreener.com
Earnings Flash (ICLR) ICON PLC Posts Q1 Revenue $2B, vs. FactSet Est of $2.01B - marketscreener.com
ICON Reports First Quarter 2025 Results - Business Wire
Icon Plc (NASDAQ: ICLR) Shares Are Down -29.22% Year To Date. - Marketing Sentinel
Checking in on Icon Plc (ICLR) after recent insiders movement - knoxdaily.com
Icon (ICLR) Downgraded by JPMorgan Amid Uncertain Market Conditi - GuruFocus
Icon (ICLR) Downgraded by JPMorgan Amid Uncertain Market Conditions | ICLR Stock News - GuruFocus
ICON plc (ICLR) Stock Analysis: Uncovering a 44.70% Potential Upside in Healthcare Research - DirectorsTalk Interviews
ICLR Stock Sees Surge of Approximately 1.66% in Last Five Days - knoxdaily.com
Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for - MSN
Icon PLC (ICLR) Stock Price Up 4.72% on Apr 23 - GuruFocus
Recent Insider Activity Could Benefit Icon Plc (ICLR) - knoxdaily.com
Icon Plc (ICLR)’s Day in Review: Closing at 137.23, Down by -1.50 - DWinneX
ICON plc (ICLR): A Deep Value Play with 53% Upside Potential - DirectorsTalk Interviews
ICON Plc stock hits 52-week low at $138.47 amid market challenges - Investing.com Canada
ICON Plc stock hits 52-week low at $138.47 amid market challenges By Investing.com - Investing.com South Africa
Clinical Trial Investigative Site Network Market Top Companies - openPR.com
Clinical trials giant Icon accused of ‘scheme to deceive market’ in new US class action - The Irish Independent
TD Cowen Downgrades Icon (ICLR) Amid Concerns Over Future Growth - GuruFocus
ICON plc (ICLR) Stock: A 54.73% Potential Upside That Investors Can’t Ignore - DirectorsTalk Interviews
Icon Plc (ICLR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.88%
자본화:
|
볼륨(24시간):